Medicaid Work Requirements Are Moving Closer: What Enrollees Should Know Before 2027
Medicaid work requirements are edging closer, and the biggest risk may be paperwork. Here is what enrollees should do now to protect coverage before 2027.
Author: Brian “Weence” Bateman
Brian “Weence” Bateman is a health and medical writer who covers public health updates, healthcare policy, and medical developments affecting communities across the United States. He works closely with dentists and healthcare providers and focuses on making complex medical information clear, accurate, and useful for everyday readers.
-
-
CMS Wants Faster Drug Prior Authorization Decisions. What the April 2026 Proposal Could Mean for Patients
CMS is proposing faster, more electronic drug prior authorization rules, but patients should know the policy is not final and current public data still leave big gaps.
-
Measles FAQs for 2026: What to Know About Symptoms, Exposure, and MMR Protection
CDC says U.S. measles activity is elevated in 2026, but risk is not equal everywhere. Here’s what symptoms, exposure timing, and MMR protection mean.
-
CMS Wants Faster Drug Prior Authorization Decisions. A New Study Shows Why That Could Matter for Patients
A CMS proposal could eventually speed some drug prior authorization decisions, but it is not final. A new JAMA study shows why even short delays matter.
-
Why the Medicaid Coverage Gap Still Falls Unevenly on People of Color in 2026
The Medicaid coverage gap still leaves many low-income adults uninsured in 2026, and the burden continues to fall disproportionately on communities of color.
-
Why more ACA shoppers chose bronze plans in 2026 — and what lower premiums can cost later
CMS says 23.1 million people picked 2026 Marketplace coverage, but many moved to bronze plans that cut monthly premiums while raising deductibles and risk.
-
Measles Cases Are Rising in 2026: What to Do if You Think You Were Exposed
CDC says measles cases are rising in 2026. Here’s what exposure means, which symptoms come first, and when to call ahead for fast, time-sensitive advice.
-
New ER Migraine Guidance: What Adults With Severe Headache Should Expect in the Emergency Department
Updated migraine guidance says adults in the ER should usually get evidence-backed non-opioid care first. Here is what to expect and when headache is an emergency.
-
Global measles outbreaks are still a travel and community risk in 2026. Here is what that means for families.
WHO’s Bangladesh outbreak update shows measles is still active globally in 2026, and travel-related cases can still spark U.S. spread where vaccination is low.
-
Medicare Picked 15 More High-Cost Drugs for Price Talks. What Changes in 2026, 2027, and 2028?
Medicare has three overlapping drug-price timelines. Here is what already changed in 2026, what starts in 2027, and why the newest 15 wait until 2028.
-
Raw Cheddar Recall and E. coli Outbreak: What Families Need to Check and Why Raw Dairy Can Be Riskier
Raw Farm’s recalled raw cheddar is tied to an open E. coli investigation. Here’s which cheeses to check, symptoms to watch for, and why kids face higher risk.
-
How Much Exercise Adults Need for Health in 2026
Federal guidance still supports a simple goal: move more, sit less, and build in both aerobic activity and strength work each week.
-
FDA Authorized a Choking Suction Device. What Has—and Hasn’t—Changed for First Aid?
The FDA’s March 2026 update did not change first-aid basics: standard choking rescue still comes first, and one suction device is only a backup.
-
Athlete’s Foot That Won’t Clear? What the New CDC Ringworm Updates Mean for Your Feet
Most athlete’s foot improves with over-the-counter treatment, but the CDC says a rash that is not better after about two weeks should be checked.
-
OSHA just updated its workplace heat program. What outdoor and indoor workers should know before summer
OSHA updated its heat hazard program ahead of summer. Here’s what that means for inspections, who faces higher risk, and signs of heat illness.
-
Emergency Preparedness & Response | Infectious Diseases | Public Health Data & Surveillance | Vaccines
CDC’s New Measles Wastewater Map: What a Positive Signal Means for Families
CDC is now posting weekly measles wastewater detections. Here is what a positive signal can mean, what it cannot tell you, and what families should do now.
-
Adults 75 and Older Need Only One RSV Shot for Now: What New 2026 Guidance Means
Current U.S. guidance says adults 75 and older who have never had an RSV shot should get one dose now, with no repeat dose advised at this time.
-
Drug Safety & Recalls | Drug Safety, Shortages & Recalls | Infectious Diseases | Maternal & Infant Health
Bicillin L-A Is Still in Short Supply: What the FDA’s Lentocilin Import Means for Syphilis Care
A federal import plan may ease some Bicillin L-A shortages, but access can still vary. For pregnancy, penicillin remains the only recommended syphilis treatment.
-
Drug Safety & Recalls | Drug Safety, Shortages & Recalls | Neurological Disorders | Nutrition & Dietary Guidance
FDA warns Parkinson’s patients and caregivers about vitamin B6 deficiency and seizure risk with carbidopa/levodopa
The FDA now requires new warnings on carbidopa/levodopa labels about vitamin B6 deficiency and possible seizures, with advice on testing and monitoring.
-
A New Study Suggests Medicare’s Insulin Cap Is Helping. Why Many Americans Still Pay More.
A new Medicare study suggests the $35 insulin cap is lowering patients’ costs. But supplies, other diabetes expenses, and gaps outside Medicare still matter.
-
FDA Cleared a New Once-Daily Psoriasis Pill. What That Means for People With Moderate to Severe Plaque Psoriasis
FDA approved Icotyde on March 17, 2026, giving some adults and teens with moderate to severe plaque psoriasis a new once-daily pill option.
-
Why a Proposed 2027 ACA Rule Could Keep Adult Dental Care Out of Marketplace Plans
A new CMS proposal could close a pathway for states to add adult dental benefits to ACA Marketplace plans in 2027, leaving many shoppers with separate coverage.
End of content
End of content
